Holen Sie sich die Stockscreener-App
0.00
100.00%
-221.38
Schlusskurs vom Vortag:
$221.38
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$6.96B
Einnahmen:
$302.00K
Nettoeinkommen (Verlust:
$-117.10M
KGV:
0.00
EPS:
-11.13
Netto-Cashflow:
$-129.13M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$0.00
52-Wochen-Spanne:
$0.00
$221.42
Cidara Therapeutics Inc Stock (CDTX) Company Profile
Firmenname
Cidara Therapeutics Inc
Sektor
Branche
Telefon
858-752-6170
Adresse
6310 NANCY RIDGE DRIVE, SAN DIEGO, CA
Compare CDTX vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CDTX
Cidara Therapeutics Inc
|
0.00 | 6.96B | 302.00K | -117.10M | -129.13M | -11.13 |
|
VRTX
Vertex Pharmaceuticals Inc
|
471.40 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
773.05 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
731.90 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
324.08 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
295.53 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Cidara Therapeutics Inc Stock (CDTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-17 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-11-17 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-11-17 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-10-16 | Eingeleitet | Morgan Stanley | Overweight |
| 2025-10-10 | Eingeleitet | JP Morgan | Overweight |
| 2025-06-18 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-03-12 | Eingeleitet | Citizens JMP | Mkt Outperform |
| 2025-01-27 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2024-12-13 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-11-08 | Eingeleitet | Guggenheim | Buy |
| 2024-08-14 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2021-12-03 | Fortgesetzt | H.C. Wainwright | Buy |
| 2021-09-22 | Hochstufung | WBB Securities | Buy → Strong Buy |
| 2021-03-04 | Eingeleitet | Aegis Capital | Buy |
| 2019-09-04 | Hochstufung | Wedbush | Neutral → Outperform |
| 2018-07-26 | Eingeleitet | Citigroup | Buy |
| 2017-04-21 | Eingeleitet | Raymond James | Strong Buy |
| 2017-04-17 | Bestätigt | H.C. Wainwright | Buy |
| 2017-04-12 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2017-04-11 | Fortgesetzt | Wedbush | Outperform |
| 2017-02-22 | Bestätigt | H.C. Wainwright | Buy |
| 2017-02-22 | Hochstufung | WBB Securities | Sell → Hold |
| 2016-12-21 | Fortgesetzt | Leerink Partners | Outperform |
| 2016-12-19 | Eingeleitet | H.C. Wainwright | Buy |
| 2016-09-23 | Herabstufung | WBB Securities | Hold → Sell |
| 2015-10-09 | Hochstufung | WBB Securities | Sell → Hold |
| 2015-05-11 | Eingeleitet | Jefferies | Buy |
| 2015-05-11 | Eingeleitet | Leerink Partners | Outperform |
| 2015-05-11 | Eingeleitet | Needham | Buy |
| 2015-05-11 | Eingeleitet | Wedbush | Outperform |
| 2015-04-23 | Eingeleitet | WBB Securities | Sell |
Alle ansehen
Cidara Therapeutics Inc Aktie (CDTX) Neueste Nachrichten
RedChip Companies Congratulates Former Client Cidara Therapeutics on Its $9.2 Billion Acquisition by Merck - Gadsden Times
Cidara Therapeutics, Inc. (CDTX) Stock Analysis: Is This Biotech Pioneer Poised for Growth? - DirectorsTalk Interviews
Cidara Therapeutics announces inclusion in the Russell 2000 and 3000 indexes - MSN
Block Trades: Is Cidara Therapeutics Inc benefiting from innovation trendsMarket Performance Report & Daily Stock Trend Watchlist - baoquankhu1.vn
Cidara Therapeutics, Inc. (CDTX) Stock Report: Navigating a Biotech Trail with a Market Cap of $6.96 Billion - DirectorsTalk Interviews
CDTX SEC FilingsCidara Theraptcs 10-K, 10-Q, 8-K Forms - Stock Titan
Point72 entities disclose 1.4% Cidara Therapeutics (CDTX) stake in Schedule 13G/A - Stock Titan
Can Cidara Therapeutics Inc. sustain its profitabilityJuly 2025 Highlights & Low Risk High Reward Ideas - mfd.ru
Is Cidara Therapeutics Inc. being accumulated by smart money - mfd.ru
Is Cidara Therapeutics Inc. stock dividend yield sustainableJuly 2025 Gainers & Free Expert Approved Momentum Trade Ideas - mfd.ru
How cyclical is Cidara Therapeutics Inc.’s revenue streamIPO Watch & Stepwise Trade Execution Plans - mfd.ru
Vivo Opportunity funds exit Cidara Therapeutics (CDTX) after merger completion - Stock Titan
Is Cidara Therapeutics Inc. benefiting from innovation trendsWeekly Trade Review & Weekly High Potential Stock Alerts - mfd.ru
RedChip Fintech & DATS Conference Replays Now Available Featuring Public Companies Shaping the Future of Digital Finance - USA Today
Merck Completes Tender Offer and Moves to Acquire Cidara Therapeutics - The Healthcare Technology Report.
Merck & Co., Inc. Q4 Earnings Call Highlights - MarketBeat
Portfolio Recap: How sensitive is Cidara Therapeutics Inc to inflationTrade Ideas & Reliable Entry Point Trade Alerts - baoquankhu1.vn
Merck (MRK) Faces One-Time Charge Due to Cidara Acquisition - GuruFocus
Merck & Co., Inc., Rahway, N.J., USA Announces Fourth-Quarter and Full-Year 2025 Financial Results; Highlights Progress Advancing Broad, Diverse Pipeline - Business Wire
Aug Highlights: How sensitive is Cidara Therapeutics Inc to inflationQuarterly Investment Review & Free High Return Stock Watch Alerts - baoquankhu1.vn
Biotech Stocks Worth WatchingJanuary 8th - MarketBeat
Top Biotech Stocks To Watch NowJanuary 2nd - MarketBeat
Cidara Therapeutics, Inc. (CDTX) Stock Analysis: Understanding the Dynamics of a $6.96 Billion Biotech - DirectorsTalk Interviews
Is Cidara Therapeutics Inc. on track to beat earnings2025 Pullback Review & Entry and Exit Point Strategies - Mfd.ru
Published on: 2026-01-28 17:40:21 - mfd.ru
Promising Biotech Stocks To ConsiderJanuary 4th - MarketBeat
Pharma News: What is the earnings history of Cidara Therapeutics IncWeekly Risk Report & Low Volatility Stock Recommendations - baoquankhu1.vn
Biotech Stocks To Add to Your WatchlistJanuary 7th - MarketBeat
Cidara Therapeutics, Inc. (CDTX) Stock Analysis: Navigating the Biotech Landscape with Potential Upside - DirectorsTalk Interviews
Biotech Stocks To Follow NowJanuary 5th - MarketBeat
Weekly Earnings: Is Cidara Therapeutics Inc benefiting from innovation trends2025 Key Lessons & High Conviction Trade Alerts - baoquankhu1.vn
Best Biotech Stocks To Keep An Eye OnJanuary 14th - MarketBeat
Support Test: Will Cidara Therapeutics Inc stock benefit from upcoming earnings reportsJuly 2025 Movers & Fast Entry Momentum Trade Alerts - Bộ Nội Vụ
Whale Trades: Will Cidara Therapeutics Inc. stock benefit from upcoming earnings reportsTrade Analysis Summary & Verified Swing Trading Watchlists - moha.gov.vn
This Biotech's Stock Price More Than Doubled on Friday. Here's Why. - MSN
Biotech Stocks To ConsiderJanuary 12th - MarketBeat
Biotech Stocks To Watch TodayJanuary 3rd - MarketBeat
Cidara Therapeutics prices upsized $350 milion stock offering at $44 - MSN
Cidara Therapeutics, Inc. Financial Disclosures & Filings - TradingView — Track All Markets
Merck to Buy Cidara in $9.2 Billion Deal as Sales Drop Looms - MSN
Top Biotech Stocks To ResearchJanuary 10th - MarketBeat
Why Cidara Therapeutics Inc. stock attracts high net worth investorsPortfolio Value Report & Long-Term Safe Investment Ideas - ulpravda.ru
What dividend safety score for Cidara Therapeutics Inc. stock2025 Trading Volume Trends & Breakout Confirmation Alerts - ulpravda.ru
Cidara Therapeutics (NASDAQ:CDTX) Upgraded at Wall Street Zen - MarketBeat
Promising Biotech Stocks To Keep An Eye OnJanuary 9th - MarketBeat
Cidara Therapeutics Completes Acquisition and Becomes Private Company - The Globe and Mail
Merck In Talks To Buy Cancer Drug-Maker Revolution Medicines In A $28 To $32 Billion Deal — Stock Soars Overnight - Benzinga
Cidara Therapeutics: Performance & Quotes, CDTX Stock Price on Nasdaq Exchange - marketscreener.com
Cidara Therapeutics, Inc.(NasdaqCM: CDTX) dropped from Russell 2000 Index - marketscreener.com
Will Cidara Therapeutics Inc. stock recover faster than marketEntry Point & AI Enhanced Trading Alerts - ulpravda.ru
Why Cidara Therapeutics Inc. stock appeals to analysts2025 Stock Rankings & Long Hold Capital Preservation Tips - ulpravda.ru
Finanzdaten der Cidara Therapeutics Inc-Aktie (CDTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.50%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):